vs
FEDERAL AGRICULTURAL MORTGAGE CORP（AGM）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
FEDERAL AGRICULTURAL MORTGAGE CORP的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$107.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 6.1%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.1%）
联邦农业抵押贷款公司（又称Farmer Mac）是由美国国会1988年依据《1987年农业信贷法案》设立、由股东持股的联邦特许企业，核心业务是搭建农业不动产及住房抵押贷款的二级市场，提升农业领域的信贷流动性，为农户、牧场主及乡村社区提供长期稳定的信贷支持。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
AGM vs PBYI — 直观对比
营收规模更大
AGM
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出21.6%
6.1%
两年增速更快
PBYI
近两年复合增速
7.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.5M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 56.3% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 6.1% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $3.69 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGMPBYI
| Q4 25 | $107.5M | $75.5M | ||
| Q3 25 | $104.0M | $54.5M | ||
| Q2 25 | $102.6M | $52.4M | ||
| Q1 25 | $94.3M | $46.0M | ||
| Q4 24 | $101.3M | $59.1M | ||
| Q3 24 | $90.3M | $80.5M | ||
| Q2 24 | $89.9M | $47.1M | ||
| Q1 24 | $93.7M | $43.8M |
净利润AGMPBYI
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | $8.8M | ||
| Q2 25 | $54.8M | $5.9M | ||
| Q1 25 | $49.7M | $3.0M | ||
| Q4 24 | $56.5M | — | ||
| Q3 24 | $49.8M | $20.3M | ||
| Q2 24 | $47.1M | $-4.5M | ||
| Q1 24 | $53.7M | $-4.8M |
毛利率AGMPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率AGMPBYI
| Q4 25 | 56.3% | 22.7% | ||
| Q3 25 | 64.1% | 17.6% | ||
| Q2 25 | 63.8% | 12.7% | ||
| Q1 25 | 66.9% | 8.7% | ||
| Q4 24 | 67.5% | 22.6% | ||
| Q3 24 | 69.0% | 27.4% | ||
| Q2 24 | 65.9% | -4.6% | ||
| Q1 24 | 72.8% | -5.3% |
净利率AGMPBYI
| Q4 25 | — | — | ||
| Q3 25 | 52.9% | 16.2% | ||
| Q2 25 | 53.4% | 11.2% | ||
| Q1 25 | 52.6% | 6.5% | ||
| Q4 24 | 55.8% | — | ||
| Q3 24 | 55.2% | 25.2% | ||
| Q2 24 | 52.4% | -9.6% | ||
| Q1 24 | 57.4% | -11.0% |
每股收益（稀释后）AGMPBYI
| Q4 25 | $3.69 | $0.26 | ||
| Q3 25 | $4.44 | $0.17 | ||
| Q2 25 | $4.48 | $0.12 | ||
| Q1 25 | $4.01 | $0.06 | ||
| Q4 24 | $4.62 | $0.40 | ||
| Q3 24 | $3.86 | $0.41 | ||
| Q2 24 | $3.68 | $-0.09 | ||
| Q1 24 | $4.28 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $30.8B | $22.7M |
| 股东权益账面价值 | $1.7B | $130.3M |
| 总资产 | $35.4B | $216.3M |
| 负债/权益比越低杠杆越低 | 17.93× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资AGMPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | $842.1M | $96.7M | ||
| Q2 24 | $923.0M | $96.8M | ||
| Q1 24 | $745.1M | $107.2M |
总债务AGMPBYI
| Q4 25 | $30.8B | $22.7M | ||
| Q3 25 | $29.2B | $34.0M | ||
| Q2 25 | $28.9B | $45.3M | ||
| Q1 25 | $28.0B | $56.7M | ||
| Q4 24 | $27.5B | $68.0M | ||
| Q3 24 | $27.2B | $79.3M | ||
| Q2 24 | $26.8B | $90.7M | ||
| Q1 24 | $26.8B | $102.0M |
股东权益AGMPBYI
| Q4 25 | $1.7B | $130.3M | ||
| Q3 25 | $1.7B | $115.3M | ||
| Q2 25 | $1.5B | $104.7M | ||
| Q1 25 | $1.5B | $97.1M | ||
| Q4 24 | $1.5B | $92.1M | ||
| Q3 24 | $1.5B | $71.1M | ||
| Q2 24 | $1.5B | $48.5M | ||
| Q1 24 | $1.5B | $51.0M |
总资产AGMPBYI
| Q4 25 | $35.4B | $216.3M | ||
| Q3 25 | $33.4B | $202.9M | ||
| Q2 25 | $33.0B | $194.9M | ||
| Q1 25 | $31.8B | $196.2M | ||
| Q4 24 | $31.3B | $213.3M | ||
| Q3 24 | $30.6B | $220.7M | ||
| Q2 24 | $30.2B | $205.0M | ||
| Q1 24 | $29.8B | $214.1M |
负债/权益比AGMPBYI
| Q4 25 | 17.93× | 0.17× | ||
| Q3 25 | 17.31× | 0.30× | ||
| Q2 25 | 18.70× | 0.43× | ||
| Q1 25 | 18.39× | 0.58× | ||
| Q4 24 | 18.48× | 0.74× | ||
| Q3 24 | 18.60× | 1.12× | ||
| Q2 24 | 17.87× | 1.87× | ||
| Q1 24 | 18.11× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $80.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流AGMPBYI
| Q4 25 | $80.1M | $14.4M | ||
| Q3 25 | $74.2M | $9.7M | ||
| Q2 25 | $-47.7M | $14.1M | ||
| Q1 25 | $-49.8M | $3.6M | ||
| Q4 24 | $612.6M | $15.6M | ||
| Q3 24 | $-44.4M | $11.0M | ||
| Q2 24 | $56.1M | $1.0M | ||
| Q1 24 | $233.3M | $11.2M |
自由现金流AGMPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $607.4M | $15.6M | ||
| Q3 24 | $-44.4M | $11.0M | ||
| Q2 24 | $52.6M | $1.0M | ||
| Q1 24 | $231.7M | — |
自由现金流率AGMPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | 599.8% | 26.4% | ||
| Q3 24 | -49.2% | 13.7% | ||
| Q2 24 | 58.5% | 2.1% | ||
| Q1 24 | 247.3% | — |
资本支出强度AGMPBYI
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 5.2% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 4.0% | 0.0% | ||
| Q1 24 | 1.7% | 0.0% |
现金转化率AGMPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.35× | 1.10× | ||
| Q2 25 | -0.87× | 2.41× | ||
| Q1 25 | -1.00× | 1.21× | ||
| Q4 24 | 10.84× | — | ||
| Q3 24 | -0.89× | 0.54× | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | 4.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
